Using Intraoperative Transrectal Ultrasound to Measure Bowel Involvement in Deep Infiltrating Endometriosis for Women Undergoing Bowel Surgery

What this Trial Is About

Researchers are evaluating intraoperative transrectal ultrasound TRUS to measure how deeply and extensively bowel tissue is affected in women with deep infiltrative endometriosis DIE involving the intestine. This study focuses on patients diagnosed before surgery using transvaginal ultrasound and MRI and who are scheduled for bowel resection. The goal is to assess how well TRUS compares to MRI in identifying the diseases extent. The study involves 15 to 40 female participants aged 18 to 55 who have bowel involvement due to DIE and require bowel resection. Before surgery, participants will undergo pelvic exams, imaging tests including transvaginal ultrasound and MRI, and pain assessments using a visual analog scale. During surgery, TRUS will be performed to measure the depth and length of rectal involvement, and these findings will be compared to the preoperative MRI results to evaluate TRUSs diagnostic accuracy. Participants will be closely monitored from enrollment through 16 months, with data collected on demographics, patient characteristics, pain levels, and surgical details. The main outcome is how TRUS measurements during surgery match with MRI findings before surgery. The study is conducted at specialized hospitals with a team of gynecologists, radiologists, and surgeons working together to analyze the results and improve understanding of bowel involvement in DIE.

Evaluation of Rectal Infiltration Depth and Length in Bowel Involvement of Deep Infiltrative Endometriosis (DIE) Using Intraoperative Transrectal Ultrasound (TRUS)